2013


To access this material please log in or register

Register Authorize
2013/№1

Clinical and prognostic significance of hypoglycaemia events in patients with myocardial infarction with ST segment elevation in combination with diabetes mellitus type 2

Karetnikova V. N., Belenkova Yu. A., Zykov M. V., Kashtalap V. V., Zhaleev B. Z., Barbarash O. L.

Keywords: hypoglycemia, myocardial infarction, ST segment elevation, type 2 diabetes mellitus

DOI: 10.18087/rhj.2013.1.1711

Relevance. Important aspect glycemic control in MI patients in combination with DM type 2 are hypoglycemia prevention. Objective. Evaluation of clinical and prognostic importance of hypoglycemia events in patients with MI with ST segment elevation against DM type 2. Materials and methods. The study included 77 patients with MI with ST segment elevation against DM type 2. Definition glycemic profile, including level glycemia evaluation at night and early morning hours (3.00 and 5.00 a.m.) were performed in all patient on days 6–10 from MI onset. Results. In this study, hypoglycemia events were registered 27 patients (35.07 %). No distinctions were revealed inthe course of hospitalization in patients with and without hypoglycemia. The analysis of hypoglycemia influence on the annual forecast for MI patients showed significant increase in number of the majority of adverse cardiovascular events. Conclusion. Hypoglycemia has more prognostic, than clinical significance. Considering adverse effect of hypoglycemia in MI patients with DM on the long-term forecast, it is necessary to consider spontaneous hypoglycemia as display (marker) of severe illness with adverse forecast.
  1. Abbate A, Biondi-Zoccai GG. The difficult task of glycaemic control in diabetics with acute coronary syndromes: finding the way to normoglycaemia avoiding both hyper- and hypoglycaemia. Eur Heart J. 2005;26 (13):1245–1248.
  2. Kosiborod M, Inzucchi SE, Krumholz HM et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117 (8):1018–1027.
  3. Nesto RW, Lago RM. Glucose: a biomarker in acute myocardial infarction ready for prime time? Circulation. 2008;117 (8):990–992.
  4. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension. 1992;20 (1):38–45.
  5. Ferrannini E, Natali A, Capaldo B et al. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension. 1997;30 (5):1144–1149.
  6. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005;26 (13):1255–1256.
  7. Pinto DS, Skolnick AH, Kirtane AJ et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;46 (1):178–180.
  8. Malmberg K, Ryden L, Wedel H et al. Waldenstrom for the DIGAMI 2 Investigator Intence metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on and morbidity. European Heart Journal. 2005;26:650–651.
  9. Kosiborod M, Inzucchi SE, Goyal A et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301 (15):1556–1564.
Karetnikova V. N., Belenkova Yu. A., Zykov M. V. et al. Clinical and prognostic significance of hypoglycaemia events in patients with myocardial infarction with ST segment elevation in combination with diabetes mellitus type 2. Russian Heart Journal. 2013;12(1):33-36

To access this material please log in or register

Register Authorize
Ru En